Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients

Ramifications of the HLA-I Allelic Reactivity of Anti-HLA-E*01:01 and Anti-HLA-E*01:03 Heavy Chain Monoclonal Antibodies in Comparison with Anti-HLA-I IgG Reactivity in Non-Alloimmunized Males, Melanoma-Vaccine Recipients, and End-Stage Renal Disease Patients

Serum anti-HLA-I IgG are present in non-alloimmunized males, cancer patients, and transplant recipients. Anti-HLA-I antibodies are also present in intravenous immunoglobulin (IVIg), prepared from the plasma of thousands of healthy donors. However, the HLA-Ia reactivity of IVIg diminishes markedly af...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Mepur H. Ravindranath, Narendranath M. Ravindranath, Fatiha El Hilali, Senthamil R. Selvan, Edward J. Filippone
Formaat: Artikel
Taal:English
Gepubliceerd in: MDPI AG 2022-03-01
Reeks:Antibodies
Onderwerpen:
HLA-Ia
HLA-Ib
HLA-E
heavy chain
open conformers
closed conformers
Online toegang:https://www.mdpi.com/2073-4468/11/1/18

Internet

https://www.mdpi.com/2073-4468/11/1/18

Gelijkaardige items